What is the difference between Montelokast and Levocetirizine?
Montelokast and Levocetirizine are drugs that work against allergic reactions, but the exact ways they do differ. The conditions for which they are suitable are those or both drugs that are caused by excessive immune systems such as pollen allergies. The function of both drugs is to disrupt an allergic reaction such as asthma, and dampen its effects. For this purpose, both Montelokast and Levocetirizine prevent certain molecules to bind to the receptor on the cells, but the exact receptor is not the same for both.
Hover hay and other allergic states that are caused by inhalation of particles occur because the body starts an unnecessarily strong response to irritating substances such as dust or pollen. The core of the body reaction is the process of inflammation. Normally, the inflammation for the body is useful because it helps to increase the temperature and irritation in places that are infected or exposed to a dangerous foreign matter. In some people, however, inflammation occurs when it is unnecessary, and for example, the lungs and nose are made without a good reason.
Inflammation in the lungs causes the airways to shrink and narrower, which prevents the air from getting in and out of the lungs. When the nose tissues are affected, the nose produces a lot of thin mucus and the eyes can also run. Some people experience a long -term allergic condition that is uncomfortable to live and therefore require special medicines to keep inflammation under control.
Both Montelokast and Levocetirizine affect the body to regulate too aggressive immune response. They do this by blocking a step in an inflammatory cascade that prevents impaired inflammation or can reduce inflammation. Although the target step on the outside of the cell includes the target step for Montelokast and Levocetirizine, the specific receptor is different for each.
Levocetirizine is a drug that is very closely related to another common allergic medicine called cetirizine. Its receptor of the target cells is the peripheral receptor H1. This receptor plays a role in recognizingThe inflammatory signals called histamines and medicine blocks receptors in identifying the instructions to continue the inflammation process.
On the other hand, Montelokast also interferes with signal intake on cells. A specific receptor of the cells that affects is the cysteinel leukotrien receptor, which is also part of the inflammatory response, but in another way to the goal of levocetirizine. Montelokast and levocetirizine can be absorbed by a gastrointestinal tract and are available together in some allergic drugs as they work in parallel.